Conclusion Research on BPC-157 and TB-500 indicates that both peptides have been studied in the context of wound healing, angiogenesis, and cellular activity
Significant B12 deficiency can lead to anemia, nerve damage and dementia
Safety Considerations and UK Regulatory Status Retatrutide is not MHRA-approved, meaning self-use outside clinical trials carries risks including product impurity, incorrect dosing, gastrointestinal adverse effects, and no pharmacovigilance oversight
doi: 10.3389/fendo.2025.1562518 Received 17 January 2025 Accepted 12 August 2025 Published 04 September 2025 Volume 16 - 2025 Edited by Sang Youb Han, Inje University Ilsan Paik Hospital, Republic of Korea Reviewed by Idris Long, University of Science Malaysia (USM), Malaysia Jorge Rico-Fontalvo, Simn Bolvar University, Colombia Updates Copyright 2025 Xu, Miao, Chen and Liao